BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28715630)

  • 1. Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease.
    Abu-Hamad S; Kahn J; Leyton-Jaimes MF; Rosenblatt J; Israelson A
    ACS Chem Neurosci; 2017 Oct; 8(10):2225-2234. PubMed ID: 28715630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
    Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria.
    Pickles S; Semmler S; Broom HR; Destroismaisons L; Legroux L; Arbour N; Meiering E; Cashman NR; Vande Velde C
    Acta Neuropathol Commun; 2016 Apr; 4(1):43. PubMed ID: 27121871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Timing and Extent of Motor Neuron Vulnerability in ALS Correlates with Accumulation of Misfolded SOD1 Protein in the Cortex and in the Spinal Cord.
    Genc B; Gozutok O; Kocak N; Ozdinler PH
    Cells; 2020 Feb; 9(2):. PubMed ID: 32098365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis.
    Tokuda E; Takei YI; Ohara S; Fujiwara N; Hozumi I; Furukawa Y
    Mol Neurodegener; 2019 Nov; 14(1):42. PubMed ID: 31744522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
    Leyton-Jaimes MF; Kahn J; Israelson A
    Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALS-associated mutation SOD1
    Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
    Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
    Hayashi Y; Homma K; Ichijo H
    Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prion-like Properties of Misfolded Cu/Zn-superoxide Dismutase in Amyotrophic Lateral Sclerosis: Update and Perspectives].
    Tokuda E; Marklund SL; Furukawa Y
    Yakugaku Zasshi; 2019; 139(7):1015-1019. PubMed ID: 31257248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Metal-Free, Disulfide Oxidized Form of Superoxide Dismutase 1 as a Primary Misfolded Species with Prion-Like Properties in the Extracellular Environments Surrounding Motor Neuron-Like Cells.
    Takashima C; Kosuge Y; Inoue M; Ono SI; Tokuda E
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New links between SOD1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis.
    Bastow EL; Peswani AR; Tarrant DS; Pentland DR; Chen X; Morgan A; Staniforth GL; Tullet JM; Rowe ML; Howard MJ; Tuite MF; Gourlay CW
    J Cell Sci; 2016 Nov; 129(21):4118-4129. PubMed ID: 27656112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice.
    Hadano S; Mitsui S; Pan L; Otomo A; Kubo M; Sato K; Ono S; Onodera W; Abe K; Chen X; Koike M; Uchiyama Y; Aoki M; Warabi E; Yamamoto M; Ishii T; Yanagawa T; Shang HF; Yoshii F
    Hum Mol Genet; 2016 Aug; 25(15):3321-3340. PubMed ID: 27439389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misfolded SOD1 and ALS: zeroing in on mitochondria.
    Pickles S; Vande Velde C
    Amyotroph Lateral Scler; 2012 Jun; 13(4):333-40. PubMed ID: 22471903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.
    Semmler S; Gagné M; Garg P; Pickles SR; Baudouin C; Hamon-Keromen E; Destroismaisons L; Khalfallah Y; Chaineau M; Caron E; Bayne AN; Trempe JF; Cashman NR; Star AT; Haqqani AS; Durcan TM; Meiering EM; Robertson J; Grandvaux N; Plotkin SS; McBride HM; Vande Velde C
    J Biol Chem; 2020 Mar; 295(12):3808-3825. PubMed ID: 32029478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly
    Malik R; Meng H; Wongkongkathep P; Corrales CI; Sepanj N; Atlasi RS; Klärner FG; Schrader T; Spencer MJ; Loo JA; Wiedau M; Bitan G
    J Biol Chem; 2019 Mar; 294(10):3501-3513. PubMed ID: 30602569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rilmenidine promotes MTOR-independent autophagy in the mutant SOD1 mouse model of amyotrophic lateral sclerosis without slowing disease progression.
    Perera ND; Sheean RK; Lau CL; Shin YS; Beart PM; Horne MK; Turner BJ
    Autophagy; 2018; 14(3):534-551. PubMed ID: 28980850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons.
    Komatsu K; Imamura K; Yamashita H; Julien JP; Takahashi R; Inoue H
    Neuroreport; 2018 Jan; 29(1):25-29. PubMed ID: 29140847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
    Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
    Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misfolded SOD1 is not a primary component of sporadic ALS.
    Da Cruz S; Bui A; Saberi S; Lee SK; Stauffer J; McAlonis-Downes M; Schulte D; Pizzo DP; Parone PA; Cleveland DW; Ravits J
    Acta Neuropathol; 2017 Jul; 134(1):97-111. PubMed ID: 28247063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants.
    Banerjee V; Shani T; Katzman B; Vyazmensky M; Papo N; Israelson A; Engel S
    ACS Chem Neurosci; 2016 Nov; 7(11):1595-1606. PubMed ID: 27540759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.